Comparative Effectiveness of Generics and Brand-name Venlafaxine On Costs and Outcomes in the Real World Medical Care of Patients with Generalized Anxiety Disorder

被引：0
|
作者：
Sicras-Mainar, A. [1 ]
Rejas-Gutierrez, J. [2 ]
Ibanez-Nolla, J. [3 ]
Navarro-Artieda, R. [4 ]
机构：
[1] Badalona Serv Assistencials SA, Directorate Planning, Badalona, Spain
[2] Pfizer SLU, Hlth Econ & Outcomes Res Dept, Alcobendas, Spain
[3] Badalona Serv Assistencials SA, Directorate Med Affairs, Badalona, Spain
[4] Hosp Badalona Germans Trias & Pujol, Dept Med Documentat, Badalona, Spain
来源：
EUROPEAN PSYCHIATRY | 2015年 / 30卷
关键词：
D O I：
10.1016/S0924-9338(15)30647-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
0829
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
    Sicras-Mainar, Antoni
    Rejas-Gutierrez, Javier
    Navarro-Artieda, Ruth
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 299 - 312
  • [2] "Real World" Difference in Effectiveness between Brand-Name and Generic Drugs - Real? or Fantasy?
    Wu, Yih-Jer
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2019, 13 (02) : 105 - 105
  • [3] Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes A Cohort Study
    Gagne, Joshua J.
    Choudhry, Niteesh K.
    Kesselheim, Aaron S.
    Polinski, Jennifer M.
    Hutchins, David
    Matlin, Olga S.
    Brennan, Troyen A.
    Avorn, Jerry
    Shrank, William H.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (06) : 400 - U56
  • [4] Evaluating Real-World Effectiveness and Safety of Generic and Brand-Name Imatinib in Chronic Myeloid Leukemia
    Muir, Michele
    Johnson, Jasmine
    Shu, Sitong
    Chen, Hui-Han
    Ozawa, Sachiko
    Muluneh, Benyam
    [J]. BLOOD, 2021, 138
  • [5] Effectiveness of Brand-Name and Generic Versions of Glimepiride for Diabetes Mellitus Care: Experience at a Medical Center in Taiwan
    Chen, Chih-Fang
    Ting, Hsien-Wei
    Yang, Cheng-Zen
    Yeh, Hung-, I
    Hung, Ta-Chuan
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2019, 13 (02) : 116 - 120
  • [6] EFFECTIVENESS AND ECONOMIC OUTCOMES OF GENERIC AND BRAND-NAME IMIPENEM/CILASTATIN IN THAI PATIENTS WITH HOSPITAL-ACQUIRED PNEUMONIA
    Klungphet, Kannika
    Sakthong, Phantipa
    Intalapaporn, Poj
    [J]. JOURNAL OF HEALTH RESEARCH, 2014, 28 (05) : 309 - 317
  • [7] Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin
    Sicras-Mainar, Antoni
    Rejas-Gutierrez, Javier
    Perez-Paramo, Maria
    Sanchez-Alvarez, Luis
    Navarro-Artieda, Ruth
    Darba, Josep
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) : 45 - 57
  • [8] CONSEQUENCES ON ECONOMIC OUTCOMES OF GENERIC VERSUS BRAND-NAME DRUGS USED IN ROUTINE CLINICAL PRACTICE: THE CASE OF TREATING PERIPHERAL NEUROPATHIC PAIN OR GENERALIZED ANXIETY DISORDER WITH PREGABALIN
    Sicras-Mainar, A.
    Rejas, J.
    Perez-Paramo, M.
    Sanchez-Alvarez, L.
    Navarro-Artieda, R.
    Darba, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S317 - S317
  • [9] Generalized anxiety disorder associated with physical comorbidities, higher medical care costs, and lost productivity
    Brandenburg, NA
    Chang, S
    Mark, T
    [J]. DEPRESSION AND ANXIETY, 2005, 22 (04) : 198 - 198
  • [10] Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings
    Sicras-Mainar, Antoni
    Blanca-Tamayo, Milagrosa
    Navarro-Artieda, Ruth
    Rejas-Gutierrez, Javier
    [J]. ATENCION PRIMARIA, 2009, 41 (02): : 77 - 84
12345